en

PRODUCT DETAIL

Faslodex 250 mg injekčný roztok

Code 89223
MA number EU/1/03/269/002
Product Form: sol inj 2x5 ml/250 mg (striek.inj.napl.skl.+2 bezp.ihly)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: AstraZeneca AB, Sweden
Therapeutic Class: 34 - ANTIHORMONA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BA Anti-estrogens
L02BA03 Fulvestrant
Shelf life: 48
Container: glass pre-filled syringe
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 25.10.2010
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 18.06.2018
eu-flag.png sk-flag.png